Duration of mild acute SARS-CoV-2 infections with Omicron depending on previous vaccinations and infections – Using data of the German DigiHero cohort study from post-pandemic winters 2022/2023 and 2023/2024

Journal of Infection and Public Health, Journal Year: 2025, Volume and Issue: 18(6), P. 102746 - 102746

Published: March 12, 2025

Protection against severe course of SARS-CoV-2 infection after COVID-19 vaccination or was extensively studied. It is unknown whether this effect also translates into shortened duration mild infections. We assessed the symptoms depending on status and previous infections among individuals with a infection. For two post-pandemic winters (2022/2023 2023/2024), in total 13,615 participants German DigiHero study reported their from September to March. Via negative binomial regression adjusting for sociodemographic factors, we studied association (days bed) number vaccinations, prior infections, time since last vaccination/and noted no major differences vaccinations short (≤21 days symptoms). Per 6 months vaccination, symptom spent bed increased by 2 % 4 %. The risk long (>21 symptoms) higher (Odds Ratio: 1.98; 95 confidence interval [1.43; 2.76]), but not (OR: 0.98; CI [0.74; 1.33]). There indication reduced during A protective prolonged disease

Language: Английский

---

Morbidity and absenteeism due to SARS-CoV-2 and seasonal influenza in healthcare personnel during the 2023-2024 season: a multicenter cohort study in Greece

American Journal of Infection Control, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

---

Evolving COVID-19 symptoms and the ongoing course of research

The Lancet Infectious Diseases, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

---